The plant will make three types of insulin, which Civica has pledged to sell for $30 a vial and $55 for a box of five pens.

CNN has been documenting illicit fentanyl users, most of whom are in recovery. The adversity they face, both physical and ...

US pharma giant Eli Lilly's Mounjaro can prove crucial in treatment of obesity & type 2 diabetes. Launched in the US in 2022, ...

The treatment has been around for over a century but insulin has still become the centre ... Unfortunately, the current drug pricing bill fails to take a holistic approach to addressing a system ...

Vykat XR is specifically indicated to address hyperphagia, or the abnormally strong sensation of hunger, which often leads to ...

US pharmaceutical giant Eli Lilly has launched its blockbuster diabetes and weight-loss drug, Mounjaro, in India following ...

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM sensor combination.

Europe has a plan to insulate itself from drug shortages, which the U.S. could also benefit from — unless tariffs get in the ...

With Eli Lilly’s Mounjaro entering India, the weight-loss drug race is on. But with steep prices and generics on the way, how ...

Sucralose, an artificial sweetener that’s often found in low- and no-calorie sweeteners and diet drinks, boosted feelings of ...